HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Russo Selected Research

Kidney Neoplasms (Kidney Cancer)

9/2022Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
1/2022Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
6/2021Resource-efficient pooled sequencing expands translational impact in solid tumors.
1/2020Comparison of Cancer Specific Outcomes following Minimally Invasive and Open Surgical Resection of Early Stage Kidney Cancer from a National Cancer Registry.
1/2019Kidney Cancer and Surgical Metastasectomy: Effective Therapy or Part of Disease Natural History?
1/2018Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study.
1/2018Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
7/2017Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
7/2016Low yield of surveillance imaging after surgery for T1 kidney cancer.
4/2016Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Russo Research Topics

Disease

152Neoplasms (Cancer)
09/2022 - 05/2002
83Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 01/2002
28Kidney Neoplasms (Kidney Cancer)
09/2022 - 11/2004
24Chronic Renal Insufficiency
01/2022 - 06/2002
22Neoplasm Metastasis (Metastasis)
11/2021 - 05/2003
8Ischemia
01/2018 - 03/2004
7Carcinoma (Carcinomatosis)
06/2022 - 11/2008
7Solitary Kidney
12/2015 - 01/2004
6Urinary Bladder Neoplasms (Bladder Cancer)
10/2020 - 08/2002
5Acute Kidney Injury (Acute Renal Failure)
01/2022 - 03/2004
4Thrombosis (Thrombus)
01/2018 - 08/2008
4Disease Progression
10/2014 - 08/2003
4Margins of Excision
01/2014 - 01/2003
4Angiomyolipoma
10/2013 - 12/2006
3Leiomyomatosis
01/2021 - 05/2014
3Melanoma (Melanoma, Malignant)
12/2020 - 06/2006
3Carcinogenesis
01/2019 - 02/2004
3Adenoma (Adenomas)
01/2018 - 12/2006
3Hypertension (High Blood Pressure)
01/2018 - 06/2002
3Lymphadenopathy
01/2017 - 09/2011
3Hypoxia (Hypoxemia)
04/2016 - 04/2007
3Transitional Cell Carcinoma
02/2007 - 08/2002
2Breast Neoplasms (Breast Cancer)
12/2020 - 11/2009
2Infections
01/2018 - 09/2011
2Lymphatic Metastasis
02/2016 - 12/2011
2Colorectal Neoplasms (Colorectal Cancer)
03/2013 - 02/2008
2Hypothermia
03/2012 - 02/2011
2Hemorrhage
09/2011 - 06/2011
2Urinary Fistula
09/2011 - 10/2010
2Prostatic Neoplasms (Prostate Cancer)
12/2010 - 02/2004
2Oxyphilic Adenoma (Oncocytoma)
12/2006 - 03/2004
2Cysts
12/2006 - 09/2006
2Venous Thrombosis (Deep-Vein Thrombosis)
11/2006 - 02/2004
2Renal Insufficiency (Renal Failure)
08/2006 - 06/2002
2Pain (Aches)
01/2006 - 03/2004
1Inflammation (Inflammations)
10/2022
1Chromosomal Instability (Chromosome Stability)
01/2022
1Hypotension (Low Blood Pressure)
01/2022
1Rare Diseases (Rare Disease)
01/2022
1Microsatellite Instability
10/2021
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Ductal Carcinoma
12/2020
1Colonic Neoplasms (Colon Cancer)
12/2020

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
09/2022 - 02/2002
9Biomarkers (Surrogate Marker)IBA
10/2022 - 12/2010
7Biological ProductsIBA
01/2022 - 07/2011
6CreatinineIBA
06/2014 - 06/2002
5Carbonic Anhydrase IXIBA
06/2015 - 04/2007
4Fumarate Hydratase (Fumarase)IBA
09/2022 - 05/2014
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
4DNA (Deoxyribonucleic Acid)IBA
06/2021 - 04/2014
4HydrogelsIBA
01/2021 - 01/2018
4GemcitabineFDA Link
10/2020 - 08/2002
4Pharmaceutical PreparationsIBA
10/2020 - 09/2004
4Sunitinib (Sutent)FDA Link
12/2017 - 09/2006
4Interferon-alpha (Interferon Alfa)IBA
03/2008 - 01/2002
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
3pazopanibFDA Link
01/2021 - 12/2017
3Cisplatin (Platino)FDA LinkGeneric
10/2020 - 02/2007
3LipidsIBA
01/2019 - 08/2007
3Messenger RNA (mRNA)IBA
01/2017 - 09/2011
2FumaratesIBA
09/2022 - 05/2014
2EnzymesIBA
09/2022 - 02/2004
2Mitochondrial DNA (mtDNA)IBA
01/2021 - 01/2019
2Opioid Analgesics (Opioids)IBA
11/2020 - 03/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2017 - 04/2007
2NucleotidesIBA
01/2017 - 02/2016
2AlbuminsIBA
01/2017 - 11/2011
2AntigensIBA
11/2016 - 06/2008
2Phenobarbital (Luminal)FDA Link
06/2015 - 07/2011
2MTOR InhibitorsIBA
04/2014 - 06/2010
2Lipocalin-2IBA
08/2013 - 07/2013
2AntibodiesIBA
03/2008 - 02/2008
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
10/2022
1Urea (Carbamide)FDA LinkGeneric
09/2022
1Furylfuramide (AF2)IBA
09/2022
1Succinate Dehydrogenase (Fumarate Reductase)IBA
09/2022
1CitrullineIBA
09/2022
1NivolumabIBA
01/2022
1LigandsIBA
01/2022
1Small Cytoplasmic RNAIBA
10/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Blood Proteins (Serum Proteins)IBA
12/2020
1IntegrinsIBA
12/2020
1Complement System Proteins (Complement)IBA
12/2020
1Extracellular Matrix ProteinsIBA
12/2020

Therapy/Procedure

139Nephrectomy
06/2022 - 03/2002
37Therapeutics
10/2022 - 01/2002
9Lymph Node Excision (Lymph Node Dissection)
10/2020 - 12/2007
8Cystectomy
10/2020 - 08/2002
8Metastasectomy
01/2019 - 11/2004
7Thrombectomy
10/2019 - 05/2011
4Aftercare (After-Treatment)
10/2022 - 09/2006
4Immunotherapy
01/2022 - 11/2016
4Drug Therapy (Chemotherapy)
02/2018 - 07/2003
4Length of Stay
11/2017 - 03/2004
3Minimally Invasive Surgical Procedures
06/2022 - 08/2014
3Urinary Diversion (Ileal Conduit)
01/2018 - 01/2003
3Neoadjuvant Therapy
02/2016 - 09/2004
2Patient-Controlled Analgesia (Analgesia, Patient Controlled)
01/2006 - 03/2004